A manufacturer learns postmarket that its drug is increasingly being linked to an adverse effect not apparent

Question:

A manufacturer learns postmarket that its drug is increasingly being linked to an adverse effect not apparent during the IND process. Explain the process required if the manufacturer decides it wants to include a warning in its labeling.

Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question

Pharmacy Practice And The Law

ISBN: 9781284154979

9th Edition

Authors: Richard R. Abood, Kimberly A. Burns

Question Posted: